|
|
|
|
|
|
20.08.25 - 19:51
|
Medtronic Has Potential To Pursue Further Divestitures: Analyst (Benzinga)
|
|
Medtronic posted better-than-expected earnings, lifted its sales forecast, and faces analyst debate on growth prospects and possible divestitures.
Latest Ratings for MDT
DateFirmActionFromTo Feb 2022Credit SuisseMaintainsOutperform Feb 2022NeedhamMaintainsBuy Feb 2022Raymond JamesMaintainsOutperform
View More Analyst Ratings for MDT
View the Latest Analyst Ratings
read more...
|
|
20.08.25 - 14:36
|
Santhera signs deal with Uniphar for GCC distribution of Agamree (PBR)
|
|
The therapy is intended for the treatment of Duchenne muscular dystrophy (DMD) in patients aged four years and above. Sales are projected to begin on a named patient
The post Santhera signs deal with Uniphar for GCC distribution of Agamree appeared first on Pharmaceutical Business review....
|
|
|
|
|
|
|
|
|
|
|
|
|
19.08.25 - 16:42
|
The Top 3 Stocks From Warren Buffett’s $3.9 Billion Spending Spree (24/7 Wall St.)
|
|
Classic Buffett Investments? Last week, Warren Buffett's Berkshire Hathaway (NYSE:BRK-A)(NYSE:BRK-B) filed its first-quarter 13-F, revealing a strategic portfolio shuffle. The filing disclosed purchases of 12 stocks, totaling approximately $3.9 billion, with six new positions: Allegion (NASDAQ:ALLE) D.R. Horton (NYSE:DHI) Lamar Advertising (NASDAQ:LAMR) Lennar (NYSE:LEN) Nucor (NYSE:NUE) UnitedHealth Group (NYSE:UNH) Despite these buys, Buffett remained a […]
The post The Top 3 Stocks From Warren Buffett's $3.9 Billion Spending Spree appeared first on 24/7 Wall St.....
|
|
|